Cilostazol as effective as aspirin

摘要

Cilostazol,an investigational antiplatelet drug,is as effective as aspirin for the secondary prevention of ischaemic stroke and is associated with fewer bleeding events,according to a study in China(published online in The Lancet Neurology,5 May,www.thelancet.com).However,a larger study is needed to confirm the findings,say the researchers.